AI Article Synopsis

  • Nucleoside and nucleotide analogues, particularly those with a sulfur atom replacing the ribose oxygen, show promise in treating viral infections and cancer.
  • A new method combines biocatalytic nucleobase diversification and chemical functionalization to create a wide variety of nucleoside analogues from 4'-thiouridine.
  • The approach successfully produced 5-iodo-4'-thiouridine enzymatically and led to a novel nucleoside analogue probe, 5-ethynyl-4'-thiouridine, which can monitor RNA synthesis in HeLa cells as a new tool for metabolic RNA labeling.

Article Abstract

Nucleoside and nucleotide analogues have proven to be transformative in the treatment of viral infections and cancer. One branch of structural modification to deliver new nucleoside analogue classes explores replacement of canonical ribose oxygen with a sulfur atom. Whilst biological activity of such analogues has been shown in some cases, widespread exploration of this compound class is hitherto hampered by the lack of a straightforward and universal nucleobase diversification strategy. Herein, we present a synergistic platform enabling both biocatalytic nucleobase diversification from 4'-thiouridine in a one-pot process, and chemical functionalization to access new entities. This methodology delivers entry across pyrimidine and purine 4'-thionucleosides, paving a way for wider synthetic and biological exploration. We exemplify our approach by enzymatic synthesis of 5-iodo-4'-thiouridine on multi-milligram scale and from here switch to complete chemical synthesis of a novel nucleoside analogue probe, 5-ethynyl-4'-thiouridine. Finally, we demonstrate the utility of this probe to monitor RNA synthesis in proliferating HeLa cells, validating its capability as a new metabolic RNA labelling tool.

Download full-text PDF

Source
http://dx.doi.org/10.1002/anie.202405040DOI Listing

Publication Analysis

Top Keywords

nucleobase diversification
12
biocatalytic nucleobase
8
rna synthesis
8
nucleoside analogue
8
diversification 4'-thionucleosides
4
4'-thionucleosides application
4
application derived
4
derived 5-ethynyl-4'-thiouridine
4
5-ethynyl-4'-thiouridine rna
4
synthesis
4

Similar Publications

Some intriguing skeletal transformations were observed in the reaction of α-hydroxypyrrolidine thymine nucleoside with different dicarbonyl compounds. In these reactions, unusual ring systems, together with new C-C bonds and stereogenic centers of defined configuration, were formed in a single step. These reactions were initiated by the nucleophilic attack of the NH of the pyrrolidine ring, present on , on one of the carbonyl moieties of a dicarbonyl reagent and seem to proceed through an enamine-iminium mechanism.

View Article and Find Full Text PDF
Article Synopsis
  • Nucleoside and nucleotide analogues, particularly those with a sulfur atom replacing the ribose oxygen, show promise in treating viral infections and cancer.
  • A new method combines biocatalytic nucleobase diversification and chemical functionalization to create a wide variety of nucleoside analogues from 4'-thiouridine.
  • The approach successfully produced 5-iodo-4'-thiouridine enzymatically and led to a novel nucleoside analogue probe, 5-ethynyl-4'-thiouridine, which can monitor RNA synthesis in HeLa cells as a new tool for metabolic RNA labeling.
View Article and Find Full Text PDF

Stereoselective Approach for the Synthesis of Diverse 1'-Modified Carbanucleosides.

Org Lett

November 2023

Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Korea.

We describe an efficient and stereoselective synthesis of 1'-substituted-β-carbocylic nucleosides via -dichlorooxirane intermediate , which directly condensed with weak nucleophiles such as pyrimidines or purines. The formation of -dichlorooxirane and direct nucleobase condensation exclusively proceeded in protic polar solvents like MeOH. This method provides a general and modular route for the late-stage diversification of 1'-modified nucleosides.

View Article and Find Full Text PDF

Targeted in vivo hypermutation accelerates directed evolution of proteins through concurrent DNA diversification and selection. Although systems employing a fusion protein of a nucleobase deaminase and T7 RNA polymerase present gene-specific targeting, their mutational spectra have been limited to exclusive or dominant C:G→T:A mutations. Here we describe eMutaT7transition, a new gene-specific hypermutation system, that installs all transition mutations (C:G→T:A and A:T→G:C) at comparable frequencies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!